Cargando…
Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient
BACKGROUND: Nelson’s syndrome is a well-described complication following bilateral adrenalectomy for management of Cushing’s disease. There is no consensus on optimal management of Nelson’s syndrome, characterized by the triad of pituitary corticotroph adenoma growth, elevated serum adrenocorticotro...
Autores principales: | He, Xin, Spencer-Segal, Joanna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648374/ https://www.ncbi.nlm.nih.gov/pubmed/33292741 http://dx.doi.org/10.1186/s40842-020-00110-7 |
Ejemplares similares
-
A prospective longitudinal study of Pasireotide in Nelson’s syndrome
por: Daniel, Eleni, et al.
Publicado: (2018) -
Pasireotide and octreotide in the treatment of severe late dumping syndrome
por: Mohammadi, Alireza, et al.
Publicado: (2017) -
Nelson's syndrome presenting as bilateral oculomotor palsy
por: Gundgurthi, Abhay, et al.
Publicado: (2013) -
Nelson Syndrome: A Case Report and Literature Review
por: Esparza-Salazar, Felipe J., et al.
Publicado: (2020) -
Effectiveness of low-dose pasireotide in a patient with Cushing’s disease: antiproliferative effect and predictivity of a short pasireotide suppression test
por: Grossrubatscher, Erika, et al.
Publicado: (2015)